Literature DB >> 18033931

Treatment of bronchiectasis in adults.

Nick H T ten Hacken1, Peter J Wijkstra, Huib A M Kerstjens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18033931      PMCID： PMC2094191          DOI： 10.1136/bmj.39384.657118.80

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  24 in total

Review 1.  Surgery vs non-surgical treatment for bronchiectasis.

Authors:  J A Corless; C J Warburton
Journal:  Cochrane Database Syst Rev       Date:  2000

Review 2.  Leukotriene receptor antagonists for non-cystic fibrosis bronchiectasis.

Authors:  J A Corless; C J Warburton
Journal:  Cochrane Database Syst Rev       Date:  2000

3.  An investigation into causative factors in patients with bronchiectasis.

Authors:  M C Pasteur; S M Helliwell; S J Houghton; S C Webb; J E Foweraker; R A Coulden; C D Flower; D Bilton; M T Keogan
Journal:  Am J Respir Crit Care Med       Date:  2000-10       Impact factor: 21.405

Review 4.  Long-acting beta-2-agonists for bronchiectasis.

Authors:  A Sheikh; D Nolan; M Greenstone
Journal:  Cochrane Database Syst Rev       Date:  2001

5.  A new system for grading recommendations in evidence based guidelines.

Authors:  R Harbour; J Miller
Journal:  BMJ       Date:  2001-08-11

6.  Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis.

Authors:  A F Barker; L Couch; S B Fiel; M H Gotfried; J Ilowite; K C Meyer; A O'Donnell; S A Sahn; L J Smith; J O Stewart; T Abuan; H Tully; J Van Dalfsen; C D Wells; J Quan
Journal:  Am J Respir Crit Care Med       Date:  2000-08       Impact factor: 21.405

Review 7.  Oral methyl-xanthines for bronchiectasis.

Authors:  K Steele; M Greenstone; J A Lasserson
Journal:  Cochrane Database Syst Rev       Date:  2001

8.  The disease-modifying effects of twice-weekly oral azithromycin in patients with bronchiectasis.

Authors:  Alicia A Cymbala; Lee C Edmonds; Michael A Bauer; Peter J Jederlinic; John J May; Jennifer M Victory; Guy W Amsden
Journal:  Treat Respir Med       Date:  2005

Review 9.  Bronchopulmonary hygiene physical therapy in bronchiectasis and chronic obstructive pulmonary disease: a systematic review.

Authors:  A Jones; B H Rowe
Journal:  Heart Lung       Date:  2000 Mar-Apr       Impact factor: 2.210

Review 10.  Inhaled steroids for bronchiectasis.

Authors:  J Kolbe; A Wells; F S Ram
Journal:  Cochrane Database Syst Rev       Date:  2000
View more
  11 in total

1.  Quality of life in patients with bronchiectasis: a 2-year longitudinal study.

Authors:  Anil Magge; Shehryar Ashraf; Alexandra L Quittner; Mark L Metersky
Journal:  Ann Transl Med       Date:  2019-07

2.  Gastro-oesophageal reflux in noncystic fibrosis bronchiectasis.

Authors:  Annemarie L Lee; Brenda M Button; Linda Denehy; John W Wilson
Journal:  Pulm Med       Date:  2011-11-10

3.  Assessment of the quantity of microorganisms associated with bronchiectasis in saliva, sputum and nasal lavage after periodontal treatment: a study protocol of a randomised controlled trial.

Authors:  Erika Horácio Pinto; Priscila Larcher Longo; Caroline Cristina Batista de Camargo; Simone Dal Corso; Fernanda De Cordoba Lanza; Rafael Stelmach; Rodrigo Athanazio; Kristianne Porta Santos Fernandes; Marcia Pinto Alves Mayer; Sandra Kalil Bussadori; Raquel Agnelli Mesquita Ferrari; Anna Carolina Ratto Tempestini Horliana
Journal:  BMJ Open       Date:  2016-04-15       Impact factor: 2.692

Review 4.  The Likelihood of Preventing Respiratory Exacerbations in Children and Adolescents with either Chronic Suppurative Lung Disease or Bronchiectasis.

Authors:  Kerry-Ann F O'Grady; Keith Grimwood
Journal:  Front Pediatr       Date:  2017-03-24       Impact factor: 3.418

5.  Cardiorespiratory Responses to Glittre ADL Test in Bronchiectasis: A Cross-Sectional Study.

Authors:  Ravoori Hena; Gopala Krishna Alaparthi; K Shyam Krishnan; R Anand; Vishak Acharya; Pretham Acharya
Journal:  Can Respir J       Date:  2018-12-17       Impact factor: 2.409

6.  Brazilian consensus on non-cystic fibrosis bronchiectasis.

Authors:  Mônica Corso Pereira; Rodrigo Abensur Athanazio; Paulo de Tarso Roth Dalcin; Mara Rúbia Fernandes de Figueiredo; Mauro Gomes; Clarice Guimarães de Freitas; Fernando Ludgren; Ilma Aparecida Paschoal; Samia Zahi Rached; Rosemeri Maurici
Journal:  J Bras Pneumol       Date:  2019-08-12       Impact factor: 2.624

7.  Gastroesophageal reflux in bronchiectasis and the effect of anti-reflux treatment.

Authors:  Zhi-Wei Hu; Zhong-Gao Wang; Yu Zhang; Ji-Min Wu; Jian-Jun Liu; Fang-Fang Lu; Guang-Chang Zhu; Wei-Tao Liang
Journal:  BMC Pulm Med       Date:  2013-06-03       Impact factor: 3.317

Review 8.  Eosinophils in the lung - modulating apoptosis and efferocytosis in airway inflammation.

Authors:  Jennifer M Felton; Christopher D Lucas; Adriano G Rossi; Ian Dransfield
Journal:  Front Immunol       Date:  2014-07-01       Impact factor: 7.561

9.  Regeneration of functional alveoli by adult human SOX9+ airway basal cell transplantation.

Authors:  Qiwang Ma; Yu Ma; Xiaotian Dai; Tao Ren; Yingjie Fu; Wenbin Liu; Yufei Han; Yingchuan Wu; Yu Cheng; Ting Zhang; Wei Zuo
Journal:  Protein Cell       Date:  2018-01-17       Impact factor: 14.870

10.  Azithromycin or erythromycin? Macrolides for non-cystic fibrosis bronchiectasis in adults: A systematic review and adjusted indirect treatment comparison.

Authors:  Wen Li; Zhong Qin; Jie Gao; Zhibin Jiang; Yihui Chai; Liancheng Guan; Yunzhi Chen
Journal:  Chron Respir Dis       Date:  2018-08-12       Impact factor: 2.444
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.